Article
Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy.
Scientific reports - 7 Jan 2025
Cherradi Sara, Roux Salomé, Dupuy Marie, Tabone-Eglinger Séverine, Tuaillon Edouard, Ziol Marianne, Assenat Eric, Duong Hong Tuan
Abstract excerpt
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Treating HCC is challenging because of the poor drug effectiveness and the lack of tools to predict patient responses. To resolve these issues, we established a patient-centric spheroid model using HepG2, TWNT-1, and THP-1 co-culture, that mimics HCC phenotype. We developed a target-independent cell killing (TICK)...
Topics
Join the communities discussing this publication.
